{
    "Trade/Device Name(s)": [
        "Elecsys CYFRA 21-1",
        "Elecsys CYFRA 21-1 CalSet",
        "Elecsys PreciControl Tumor Marker"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K160915",
    "Predicate Device Reference 510(k) Number(s)": [
        "K100831",
        "K112624",
        "K050387"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OVK",
        "JIT",
        "JJY"
    ],
    "Summary Letter Date": "November 7, 2016",
    "Summary Letter Received Date": "November 8, 2016",
    "Submission Date": "November 7, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.6010",
        "862.1660",
        "862.1150"
    ],
    "Regulation Name(s)": [
        "Tumor-Associated Antigen Immunological Test System",
        "Secondary, calibrator",
        "Multi-analyte controls, all kinds (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "cancer molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "Cytokeratin 19 fragments",
        "CYFRA 21-1",
        "AFP",
        "CEA",
        "CA 15-3 II",
        "CA 125 II",
        "Ferritin",
        "fPSA",
        "tPSA",
        "CA 19-9"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (Li-Heparin, K2-EDTA, K3-EDTA)"
    ],
    "Specimen Container(s)": [
        "Serum Separator Tube (SST)",
        "Plasma Primary Tube",
        "Plasma Separation Tube (PST)"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys immunoassay analyzers",
        "cobas e immunoassay analyzers",
        "cobas e 411",
        "cobas e 601"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay",
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Quantitative determination",
        "Calibration",
        "Quality control"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Roche Elecsys CYFRA 21-1 cancer immunoassay, CalSet calibrator, and PreciControl Tumor Marker for monitoring disease progression in lung cancer patients",
    "Indications for Use Summary": "Elecsys CYFRA 21-1 is an immunoassay for the in vitro quantitative determination of cytokeratin 19 fragments in human serum and plasma, aiding in monitoring disease progression and treatment in lung cancer patients; CalSet calibrates the assay, and PreciControl Tumor Marker provides quality control on Elecsys and cobas e analyzers",
    "fda_folder": "Immunology"
}